http://purl.org/np/RA-S5Zul1JQfEWnQOiYZDDksOnO6BQ-Rq3cU7t2qcNSMc
.trig | .trig.txt | .jelly | .jelly.txt | .jsonld | .jsonld.txt | .nq | .nq.txt | .xml | .xml.txt
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://www.w3.org/ns/prov#> .
@prefix this: <http://purl.org/np/RA-S5Zul1JQfEWnQOiYZDDksOnO6BQ-Rq3cU7t2qcNSMc> .
@prefix sub: <http://purl.org/np/RA-S5Zul1JQfEWnQOiYZDDksOnO6BQ-Rq3cU7t2qcNSMc#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
<http://purl.obolibrary.org/obo/DOID_12800> bl:category bl:Disease .
sub:association a rdf:Statement;
rdf:object <http://purl.obolibrary.org/obo/DOID_12800>;
rdf:predicate bl:treats;
rdf:subject <https://identifiers.org/drugbank:DB01279>;
rdfs:label "naglazyme galsulfase is indicated for patients with mucopolysaccharidosis vi mps vi maroteaux lamy syndrome naglazyme has been shown to improve walking and stair climbing capacity naglazyme is a hydrolytic lysosomal glycosaminoglycan gag specific enzyme indicated for patients with mucopolysaccharidosis vi mps vi maroteaux lamy syndrome naglazyme has been shown to improve walking and stair climbing capacity 1";
bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
bl:provided_by <https://w3id.org/um/NeuroDKG>;
bl:relation schema:TreatmentIndication .
<https://identifiers.org/drugbank:DB01279> bl:category bl:Drug .
}
sub:provenance {
sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "V1yjgIDiz/jmf/hHoukarQx+1UkKdp4S1AigD1x0g8m+3IYzdlXXDQ12hf6uRbW4s7pVMijxyLD2ss4eqSqGfrltYb9rI2iQ9CpqRLqFq06WgopUK+/D236CFyzrjwE0uVLl9ol44RKNzmhIUasmBZzVMvWBwUWb+ThLS4ny5mY=";
npx:hasSignatureTarget this: .
this: dcterms:created "2021-07-03T15:45:25.268+02:00"^^xsd:dateTime;
dcterms:creator orcid:0000-0002-1468-3557;
nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}